Export & Import of Lethal Agents Mediated by TolC
出口
基本信息
- 批准号:6680962
- 负责人:
- 金额:$ 24.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-05 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli antibacterial agents antibody bacterial genetics bacterial proteins bacterial toxins colicines immunologic substance development /preparation laboratory rabbit membrane permeability membrane transport proteins mutant protein protein interaction protein structure function protein transport
项目摘要
DESCRIPTION (provided by applicant): Transport of molecules across biological membranes is a fundamental process shared by all living cells. In Gram-negative bacteria, such as Escherichia coil, transport occurs across two membranes, of which the outer membrane represents the first permeability barrier. Outer membrane protein-mediated transport is needed to bring nutrients inside and expel unwanted metabolites and inhibitors. Ironically, toxic biomolecules and infectious agents, present in the hostile environment in which bacteria live, frequently exploit these outer membrane proteins to gain entry into the cell. The focus of this research is a unique outer membrane protein, TolC, which mediates the diffusion of a diverse group of molecules including the export of alpha-hemolysin and the efflux of antibiotics. Despite the resolution of TolC's three-dimensional structure, the role of individual residues and the mechanism by which it accomplishes the transport of a diverse group of molecules remains poorly understood. Moreover, it is unknown how TolC interacts with other proteins of the inner membrane to form the complexes that facilitate the two-way transport activity. The present study is being undertaken to examine the role of TolC in export (antibiotic) and import (colicin E1 ), as well as to examine its interactions with other proteins of the transport complexes. Identification of functionally critical TolC residues and the various protein-protein interactions that must occur to accomplish the diverse transport activities will be achieved through employing a combination of genetic, structural, and biochemical approaches; available preliminary data concerning all aspects of the project strongly reflect their feasibility.The presence of TolC and its homologues in other Gram-negative bacteria demonstrates the broader relevance of this unique multifunctional protein. Besides the obvious role of TolC in antibiotic resistance, its ability to mediate the secretion of a variety of virulence factors in pathogenic bacteria makes it a medically important subject of investigation.
描述(由申请人提供):分子在生物膜上的运输是所有活细胞共有的基本过程。在革兰氏阴性细菌中,如埃希氏螺旋菌,转运发生在两层膜上,其中外膜是第一个渗透性屏障。需要外膜蛋白介导的运输将营养物质带入体内并排出不需要的代谢物和抑制剂。具有讽刺意味的是,存在于细菌生存的恶劣环境中的有毒生物分子和感染因子经常利用这些外膜蛋白进入细胞。本研究的重点是一种独特的外膜蛋白,TolC,它介导多种分子的扩散,包括α -溶血素的输出和抗生素的流出。尽管已经确定了TolC的三维结构,但个体残基的作用以及它实现多种分子运输的机制仍然知之甚少。此外,目前尚不清楚TolC如何与内膜的其他蛋白质相互作用,形成促进双向运输活性的复合物。目前正在进行的研究是为了检查TolC在出口(抗生素)和进口(粘菌素E1)中的作用,以及检查它与运输复合物的其他蛋白质的相互作用。鉴定功能关键的TolC残基和完成各种运输活动必须发生的各种蛋白质-蛋白质相互作用将通过采用遗传、结构和生化方法的组合来实现;有关该项目各方面的现有初步数据有力地反映了其可行性。TolC及其同源物在其他革兰氏阴性菌中的存在证明了这种独特的多功能蛋白的广泛相关性。除了TolC在抗生素耐药中的明显作用外,其介导病原菌多种毒力因子分泌的能力使其成为医学上重要的研究课题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAJEEV MISRA其他文献
RAJEEV MISRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAJEEV MISRA', 18)}}的其他基金
Detailed mapping of drug binding and translocation sites in the AcrB pump protein
AcrB 泵蛋白中药物结合和易位位点的详细图谱
- 批准号:
9210599 - 财政年份:2016
- 资助金额:
$ 24.21万 - 项目类别:
Detailed mapping of drug binding and translocation sites in the AcrB pump protein
AcrB 泵蛋白中药物结合和易位位点的详细图谱
- 批准号:
9112330 - 财政年份:2016
- 资助金额:
$ 24.21万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
2185646 - 财政年份:1992
- 资助金额:
$ 24.21万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
6018920 - 财政年份:1992
- 资助金额:
$ 24.21万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
6179580 - 财政年份:1992
- 资助金额:
$ 24.21万 - 项目类别:
相似海外基金
Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
- 批准号:
23K07930 - 财政年份:2023
- 资助金额:
$ 24.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
- 批准号:
23K07918 - 财政年份:2023
- 资助金额:
$ 24.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
- 批准号:
472342 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
- 批准号:
22K07406 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
- 批准号:
569719-2022 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2021
- 资助金额:
$ 24.21万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2021
- 资助金额:
$ 24.21万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2020
- 资助金额:
$ 24.21万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
- 批准号:
531450-2018 - 财政年份:2020
- 资助金额:
$ 24.21万 - 项目类别:
Collaborative Research and Development Grants